| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $753.0M | — | +7.1% |
| Cost of Revenue | $397.7M | — | +8.6% |
| Gross Profit | $355.3M | — | +5.4% |
| R&D Expense | $19.2M | — | +1.8% |
| SG&A Expense | $213.7M | — | +6.7% |
| Operating Income | $120.1M | — | +4.9% |
| Pre-tax Income | $105.3M | — | -12.7% |
| Income Tax | $24.1M | — | +11.7% |
| Net Income | $81.4M | — | -18.1% |
| EPS (Basic) | $1.36 | — | -16.0% |
| EPS (Diluted) | $1.36 | — | -16.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $504.8M | +132.1% | +5.7% |
| Inventory | $576.7M | -5.2% | +7.2% |
| Current Assets | $1.30B | +26.3% | +8.9% |
| Total Assets | $2.60B | +11.0% | +8.2% |
| Current Liabilities | $452.0M | +5.1% | -16.0% |
| Long-term Debt | $1.12B | +20.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$143.7M | — | -19.5% |
| Capital Expenditures | $19.2M | — | +70.4% |
| Investing Cash Flow | -$19.2M | — | -70.4% |
| Financing Cash Flow | $164.9M | — | +39.6% |
| Free Cash Flow | -$162.9M | — | -23.8% |
| +21.2% |
| Total Liabilities | $1.77B | +13.9% | +9.6% |
| Stockholders' Equity | $825.1M | +5.3% | +5.7% |